Gan & Lee Pharmaceuticals. Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals.

603087

Rankning i aktier #3011
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Aktiekurs
$10.03
Marknadsvärde
$5.99B
Förändring (1 dag)
-3.71%
Förändring (1 år)
2.30%
Land
CN
Handel Gan & Lee Pharmaceuticals. (603087)

Kategori

Healthcare
Utdelningshistorik för Gan & Lee Pharmaceuticals. (603087)
Gan & Lee Pharmaceuticals. (aktiens symbol: 603087) har gjort totalt 7 utdelningsbetalningar.
Summan av alla utdelningar (justerat för aktiesplitar) är: $3.76
Utdelningsavkastning (TTM): 0.0149
Utdelningsbetalningar för Gan & Lee Pharmaceuticals. (603087) från 2020 till 2026
Årliga utdelningsbetalningar
År Utdelning (justerat för aktiesplitar) Ändra
2026 (TTM) $1.00 0.00%
2025 $1.00 42.86%
2024 $0.7 133.33%
2022 $0.3 -25.00%
2021 $0.4 12.01%
2020 $0.3571 0.00%
Lista över alla utdelningsbetalningar
År Utdelning Ändra
2026 (TTM) $1.00 0.00%
2025 $1.00 42.86%
2024 $0.7 133.33%
2022 $0.3 -25.00%
2021 $0.4 12.01%
2020 $0.3571 0.00%
Utdelningar för liknande företag eller konkurrenter
Företag Antal utdelningsbetalningar Land
0.00%
US
27.00%
FR
52.00%
JP
175.00%
US
7.00%
CH